How did PTCT's Q1 2025 EPS forecast compare to past trends?

PTCT's Q1 2025 EPS forecast was not available, and the company's financial performance in Q1 2024 and Q1 2023 showed a decline in EPS compared to the previous quarter, indicating a potential continuation of the downward trend in Q1 2025 if the company's financial performance does not improve.

The company's EPS in Q1 2024 was -$1.2, which was an improvement from the EPS of -$1.88 in Q1 2023. However, the EPS in Q1 2023 was -$1.78, which was a decrease from the EPS of -$1.6 in Q1 2022. This suggests that the company's financial performance has been declining over the past few quarters, and the trend may continue in Q1 2025 if the company does not take steps to improve its financial performance.

|code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS|market_code|
|---|---|---|---|---|---|---|
|PTCT|PTCT.O|Ptc Therapeutics|2023 Q2|-24.882629107981234|-2.66|185|
|PTCT|PTCT.O|Ptc Therapeutics|2023 Q3|-15.032679738562091|-1.76|185|
|PTCT|PTCT.O|Ptc Therapeutics|2024 Q1|36.170212765957444|-1.2|185|

|code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS|market_code|
|---|---|---|---|---|---|---|
|PTCT|PTCT.O|Ptc Therapeutics|2022 Q2|-26.785714285714285|-2.13|185|
|PTCT|PTCT.O|Ptc Therapeutics|2022 Q3|19.04761904761904|-1.53|185|
|PTCT|PTCT.O|Ptc Therapeutics|2023 Q1|-5.61797752808988|-1.88|185|

|code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS|market_code|
|---|---|---|---|---|---|---|
|PTCT|PTCT.O|Ptc Therapeutics|2021 Q2|39.568345323741006|-1.68|185|
|PTCT|PTCT.O|Ptc Therapeutics|2021 Q3|-83.49514563106794|-1.89|185|
|PTCT|PTCT.O|Ptc Therapeutics|2022 Q1|2.732240437158472|-1.78|185|